Home / Resource Library / Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia

Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia

Study investigated outcomes following interactions with ibrutinib in patients with CLL.